The Promise of Home Monitoring

Remote surveillance of retinal disease enables patient treatments to align with disease progression rather than a prespecified clinic visit schedule.

By: Eric W. Schneider, MD

Ophthalmology Management July 1, 2025 Vol 29, Issue July/August 2025 Page(s): 18, 19

5 Key Takeaways

1

Remote patient monitoring (RPM) spending by Medicare surged from $6.8 million in 2019 to $194.5 million in 2023.
2

Home-based functional testing, such as preferential hyperacuity perimetry, improves management of age-related macular degeneration.
3

The FDA approved the SCANLY Home OCT device, enabling home monitoring of AMD-related conditions and alerting physicians to critical changes.
4

Outsourcing device management to RPM service providers enhances patient adherence and allows practices to focus on patient care.
5

Home monitoring can reduce patient visit frequency by nearly 48%, optimizing clinic capacity and improving patient retention.

Eric W. Schneider, MD

Specialties: Ophthalmology; retinal disease home monitoring

Bio: Eric W. Schneider, MD, writes on ophthalmic applications of remote patient monitoring and home-based surveillance for retinal disease. In Ophthalmology Management, he discussed how home monitoring can support earlier detection and treatment alignment in age-related macular degeneration, including evidence related to preferential hyperacuity perimetry and the HOME/AREDS2 study.

PentaVision

Ophthalmology Management

The Promise of Home Monitoring

5 Key Takeaways

1

2

3

4

5

Recommendations